A phase II, randomized, controlled trial of nivolumab in combination with BMS-986253 or cabiralizumab in advanced hepatocellular carcinoma (HCC) patients

被引：0

作者：

Welling, Theodore

Beri, Nina

Siolas, Despina

Cohen, Deirdre Jill

Becker, Daniel Jacob

Zhong, Hua

Wu, Jennifer J.

Oberstein, Paul Eliezer

Karasic, Thomas Benjamin

机构：

[1] NYU Langone Hlth, Laura & Isaac Perlmutter Canc Ctr, New York, NY USA

[2] NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USA

[3] NYU, Mattituck, NY USA

[4] ECOG ACRIN, New York, NY USA

[5] NYU, Langone Med Ctr, Dept Med Oncol, New York, NY USA

[6] NYU Langone Hlth, New York, NY USA

[7] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS598

引用

页数：1